Cargando…
The risk between thyrotropin suppression and bone mineral density in differentiated thyroid cancer
The effect of thyroid stimulating endocrine (TSH) suppression medical aid on bone mineral density (BMD) of patients with differentiated thyroid carcinoma (DTC) or differentiated thyroid malignant neoplastic disease is still controversial. Our aim was to investigate the effect of TSH suppression ther...
Autores principales: | Zou, Yang, Li, Bin, Wang, Xiaodong, Mao, Jingxin, Zhang, Yanyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726344/ https://www.ncbi.nlm.nih.gov/pubmed/36482589 http://dx.doi.org/10.1097/MD.0000000000031991 |
Ejemplares similares
-
Effect of thyrotropin suppressive therapy on heart rate variability and QT dispersion in patients with differentiated thyroid cancer
por: Liu, Chunhua, et al.
Publicado: (2020) -
Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report
por: Yang, Jing, et al.
Publicado: (2017) -
Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women
por: Shi, Liang, et al.
Publicado: (2016) -
Association between urine caffeine metabolites and bone mineral density: A population-based study
por: Tan, Ning, et al.
Publicado: (2023) -
Association of urinary caffeine and caffeine metabolites with bone mineral density in children and adolescents
por: Luo, Juan, et al.
Publicado: (2022)